Clinical trial
Effectiveness of Quercetin In The Treatment of SARS-COV 2
NCT04853199 is registered in ClinicalTrials.gov with Hôpital Universitaire Sahloul as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Quercetin In The Treatment of SARS-COV 2
- Lead sponsor
- Hôpital Universitaire Sahloul
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 1, 2021
- Completion date
- August 30, 2021
- Enrollment
- 200 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
sars (severe acute respiratory syndrome)